Avigen is a UK-based Contract Research Organisation (CRO) specialising in oncology, immuno-oncology, and biologics.
Avigen combines deep biological expertise with advanced microfluidic technologies to support the development of next-generation immunotherapies. We generating robust preclinical data to support our clients in making confident, data-driven decisions early in the development process.
We partner with biotechnology companies, pharmaceutical organisations, and academic institutions to accelerate and de-risk immunotherapy discovery and validation, helping to advance promising therapies towards the clinic.
Interested in learning more or collaborating? We are eager to partner with biotech and pharma teams focused on cellular immunotherapies for solid tumours.